1. Update on Exhaled Nitric Oxide in Clinical Practice.
- Author
-
Mummadi SR and Hahn PY
- Subjects
- Administration, Inhalation, Adrenal Cortex Hormones therapeutic use, Asthma drug therapy, Asthma immunology, Biomarkers, Humans, Inflammation, Insurance Coverage, Nitric Oxide immunology, Point-of-Care Testing economics, Reimbursement Mechanisms, Th2 Cells immunology, Asthma diagnosis, Breath Tests methods, Nitric Oxide analysis
- Abstract
Asthma is characterized by chronic airway inflammation. Fractional exhaled nitric oxide (Feno) has emerged as a marker of T-helper cell type 2-mediated allergic airway inflammation. Recent studies suggest a role for Feno testing as a point-of-care tool in the management of patients with asthma. This Topics in Practice Management article reviews current coverage and reimbursement issues related to Feno testing and provides an overview of pertinent recent studies., (Copyright © 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF